跳到主要內容
big screen image small screen image
Font Size
A
A
A
轉寄 轉寄
(Non-exclusive License) Technology Transfer Enterprise Selection Announcement – Probiotics for Enhancing Intestinal Glucagon-Like Peptide-1 (GLP-1) Secretion and Its Application in Diabetes Prevention
Date of Announcement
2025-11-12

1、Technology:Probiotics for Enhancing Intestinal Glucagon-Like Peptide-1 (GLP-1) Secretion and Its Application in Diabetes Prevention

2、Inventor:Prof. Ming-Ju Chen / Department of Animal Science and Technology, National Taiwan University.

3、Enterprise Eligibility:

(1)Industry Category: pharmaceutical companies or biotechnology companies

(2)Required Technical Know-how:None

(3)Required Machinery and Equipment: None

(4)Required Research or Technical Staff:None

(5)Other Requirements:None

 

4、How to apply:Please go to the Center of Industrial-Academic Cooperation of the Office of Research and Development to inquire about relevant information.

5、Announcement period:Applications will be accepted from the announcement date.

 

6、Contact window:

Intellectual Property & Licensing Manager:Sierra Wang

TEL:+886-2-3366-6654

Email: sierrawang@ntu.edu.tw

 

7、Please refer to the attachment for the technical disclosure information of this case, and download the documents required for the application from the link (https://ord.ntu.edu.tw/w/ordntu/Alumnus_20072014421396936)

File download:
ProbioticsforEnhancingIntestinalGlucagon-LikePeptide-1(GLP-1)SecretionandItsApplicationinDiabetesPrevention
File size: 596kb